Concomitant illness in patients treated for Hodgkin's disease.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001847:Bone Diseases / Q000209:etiology; D002318:Cardiovascular Diseases / Q000209:etiology; D003131:Combined Modality Therapy; D005260:Female; D006689:Hodgkin Disease / Q000150:complications* / Q000628:therapy; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000209:etiology; D007239:Infections / Q000209:etiology; D007247:Infertility, Female / Q000209:etiology; D007248:Infertility, Male / Q000209:etiology; D007938:Leukemia / Q000209:etiology; D008171:Lung Diseases / Q000209:etiology; D008223:Lymphoma / Q000209:etiology; D008297:Male; D009190:Myelodysplastic Syndromes / Q000209:etiology; D009378:Neoplasms, Multiple Primary / Q000209:etiology; D009381:Neoplasms, Radiation-Induced / Q000209:etiology; D011878:Radiotherapy / Q000009:adverse effects; D013156:Splenectomy / Q000009:adverse effects; D013959:Thyroid Diseases / Q000209:etiology